Comparison Of Outcome Measures During Treatment With The Proprietary Harpagophytum Extract Doloteffin In Patients With Pain In The Lower Back, Knee Or Hip

Effect Decrease
Trial Design Cohort
Trial Length n/a
Number of Subjects 227
Sex n/a
Notes for this study:
60mg Harpagoside daily for 8 weeks (brand name Doloteffin) provided some relief to patients when assessed by WOMAC, Modified HAQ, and Arhus index; more efficacy was noted in persons worse off with pain and disease progression

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.